Michael J. Caplan
14Patents
8h-index
9Co-inventors
65Inventor score
Filing activity: Nov 21, 1996 → Sep 16, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6143495A | Unimolecular segment amplification and sequencing | Chemistry; Metallurgy | 252 | Expired |
| US6329150A | Unimolecular segment amplification and sequencing | Chemistry; Metallurgy | 120 | Expired |
| US6344475B1 | Conductance of improperly folded proteins through the secretory pathway | Physics | 29 | Expired |
| US8815251B2 | Microbial delivery system | Human Necessities | 20 | Active |
| US6299875A | Methods to block IGE binding to cell surface receptors of mast cells | Emerging Cross-Sectional Technologies | 19 | Expired |
| US8153414B2 | Microbial delivery system | Human Necessities | 16 | Expired |
| US8246945B2 | Methods and reagents for decreasing clinical reaction to allergy | Human Necessities | 16 | Active |
| US8889117B2 | Modular nanoparticles for adaptable vaccines | Performing Operations; Transporting | 14 | Active |
| US9999600B2 | Nanoparticle compositions | Emerging Cross-Sectional Technologies | 4 | Active |
| US9597385B2 | Nanoparticles for treatment of allergy | Human Necessities | 3 | Active |
| US9539217B2 | Nanoparticle compositions | Emerging Cross-Sectional Technologies | 3 | Active |
| US8058314B2 | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease | Physics | 1 | Active |
| US10265407B2 | Modular nanodevices for smart adaptable vaccines | Chemistry; Metallurgy | 1 | Active |
| US11071776B2 | Nanoparticles for treatment of allergy | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.